South Africa secured a rare consensus among G20 finance ministers and central bank governors, concluding a two-day meeting ...

GSK was trying to revive a product pulled from US markets in 2022. Its shares fell 4.6 per cent, or 65p, to 1348p.

Long-acting injectable PrEP may improve access, protection and adherence, especially for young people and pregnant women, according to Hasina Subedar, a senior technical advisor at South Africa’s ...

A team of leading infectious disease scientists from academia and industry have been awarded £17.9 million to identify new ...

HIV pharma leaders are in Kigali, Rwanda for IAS 2025, touting their latest advancements in HIV and PrEP development on the ...

We have launched a new five-year partnership with GlaxoSmithKline (GSK) to enhance the capabilities of African scientists in modern analytical skills.

After nearly 25 years with Sanofi, Sanjay Gurunathan, M.D., has left for GSK, where he will lead vaccine and infectious disease R&D.

A proposed regulatory change would allow Elon Musk’s satellite company and others like it to get a license without having to sell shares to Black South Africans.

President Trump confronted South African President Cyril Ramaphosa, who pushed back on claims about White genocide in South Africa.

Tech billionaire Elon Musk was born in South Africa but emigrated at age 17 and eventually became a naturalized U.S. citizen.

Police launched a manhunt for gunmen who killed eight customers at a tavern in Durban, South Africa.

The Trump administration’s hostile approach to South Africa was shaped by a convergence of factors.